摘要
急性脑血管病是目前死亡率最高的三大疾病之一,尤以缺血性脑血管病为最多见(约70%)。除高发病率、致死率及复发率外,由此引起的失语、痴呆、瘫痪等后遗症不仅使患者的生存质量下降,更给社会和家庭带来沉重负担。丹红注射液是由丹参、红花两味中药经合理组方、现代化生产工艺精制而成的复方提取液注射剂,其药理作用为活血化瘀、通脉疏络,具有改善血管缺血、缺氧,防止血小板聚集,降低血黏度,改善微循环障碍和血管代谢障碍等功能,本文就丹红注射液对脑缺血再灌注损伤干预作用的研究作一综述。
Acute cerebrovascular disease is on of the three diseases which have highest mortality rate. The ischemic cerebrovasculardisease is most common （about 70%）. In spite of high rate of morbidity, fatality and recurrence, the sequelae caused by it, such asaphasias, dementia and paralysis, not only reduce the life quality of patients, but also place a huge burden on their family and society.Danhong injection is a compound extract injection composed with radix salvia and safflower carthamus by reasonable compatibility andmodern production technique. Its pharmacological functions include activating blood circulation and resolving blood stasis, dredgingmeridians and smoothing collateral. It can improve the vascular ischemia and anoxia, prevent platelet aggregation, low blood viscosityand improve microcirculation disturbance and vascular metabolic disorders. This paper summarizes the intervention effect of Danhonginjection on cerebral ischemia-reperfusion injury.
出处
《中医临床研究》
2014年第30期53-56,共4页
Clinical Journal Of Chinese Medicine
关键词
丹红
脑缺血再灌注
干预
Danhong
Cerebral ischemia-reperfusion
Intervention
